Forghani B, Dupuis K W, Schmidt N J
Viral and Rickettsial Disease Laboratory, California State Department of Health Services, Berkeley 94704.
J Clin Microbiol. 1990 Nov;28(11):2500-6. doi: 10.1128/jcm.28.11.2500-2506.1990.
By competition neutralization assay using monoclonal antibodies (MAbs) to varicella-zoster virus (VZV) glycoproteins (gps), we attempted to determine the topographical relationship of epitopes which are functional in VZV neutralization. MAbs against gpI interfered moderately to strongly with neutralization of MAbs against gpIII, and one antigenic domain with two distinct epitopes was identified on gpIII. Competition neutralization assays performed with MAbs to gpI revealed at least three distinct antigenic domains: the first contained two complement-dependent neutralizing epitopes; the second contained five complement-dependent neutralizing, overlapping epitopes and one nonneutralizing, nonoverlapping epitope; and the third contained one complement-enhanced neutralizing epitope. Competition neutralization assays performed with MAbs to gpIV showed one antigenic domain with two distinct epitopes which competed with nonneutralizing gpI MAbs. gpII did not interfere with neutralization of gpI, gpIII, or gpIV. Our data suggest that neutralizing and nonneutralizing MAbs can interfere with the action of viral neutralization either by inhibition or by enhancement. This report describes the epitope mapping of VZV gps by a functional biological assay.
通过使用针对水痘-带状疱疹病毒(VZV)糖蛋白(gp)的单克隆抗体(MAb)进行竞争中和试验,我们试图确定在VZV中和中起作用的表位的拓扑关系。抗gpI的MAb对抗gpIII的MAb的中和作用有中度到强烈的干扰,并且在gpIII上鉴定出一个具有两个不同表位的抗原结构域。用抗gpI的MAb进行的竞争中和试验揭示了至少三个不同的抗原结构域:第一个包含两个补体依赖性中和表位;第二个包含五个补体依赖性中和、重叠表位和一个非中和、非重叠表位;第三个包含一个补体增强中和表位。用抗gpIV的MAb进行的竞争中和试验显示一个具有两个不同表位的抗原结构域,它们与非中和性gpI MAb竞争。gpII不干扰gpI、gpIII或gpIV的中和作用。我们的数据表明,中和性和非中和性MAb可以通过抑制或增强来干扰病毒中和作用。本报告描述了通过功能性生物学试验对VZV gp进行的表位作图。